Home Webtool Download Documentation Contact

Targets of perturbagens

Perturbagen ID : CID57778

Perturbagen : Advate; Afstyla; Antihemophilic factor (recombinant); Antihemophilic factor (recombinant), plasma/albumin-free method; Antihemophilic factor recombinant; Antihemophilic factor, recombinant; Antihemophilic factor,recombinant; Antivenin; Factor viii (rdna); Factor viii (recombinant); Factor viii recombin; Factor viii, recombinant; Helixate fs; Human factor viii (recombinant); Human factor viii recombinant; Kogenate - pws iv 1000i.u./vial; Kogenate - pws iv 250i.u./vial; Kogenate - pws iv 500i.u./vial; Kogenate fs; Kogenate fs -(with bio-set); Kogenate pws 1000iu/vial; Kogenate pws 250iu/vial; Kogenate pws 500iu/vial; Kovaltry; Monoclate-p; Novoeight; Nuwiq; Rahf; Recombinant antihemophilic factor viii; Recombinate; Recombinate pws inj 1000i.u./vial; Recombinate pws inj 250i.u./vial; Recombinate pws inj 500i.u./vial; Refacto; Wilate - von willebrand factor/coagulation factor viii complex (human); Xyntha; Xyntha solofuse

Target	Effect	Reference
PHYH	-1	DrugBank
F10	1	DrugBank
F9	2	DrugBank
VWF	2	DrugBank
ASGR2	2	DrugBank
HSPA5	2	DrugBank
CALR	2	DrugBank
CANX	2	DrugBank
LMAN1	2	DrugBank
LRP1	2	DrugBank
MCFD2	2	DrugBank